About N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide
N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide (PubChem CID 118454747) has the molecular formula C32H36FN5O3
and a molecular weight of 557.67 g/mol. Its IUPAC name is N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide.
Molecular Properties
| Compound Name | N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide |
| PubChem CID | 118454747 |
| Molecular Formula | C32H36FN5O3 |
| Molecular Weight | 557.67 g/mol |
| Exact Mass | 557.28 |
| IUPAC Name | N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide |
| SMILES | CC(C)c1ccc(-c2ccc(Oc3cc(C(=O)NC4CC5(CNC5)C4)c(F)cc3CN3C[C@@H](C)CC3=O)cc2)nn1 |
| InChI | InChI=1S/C32H36FN5O3/c1-19(2)27-8-9-28(37-36-27)21-4-6-24(7-5-21)41-29-12-25(31(40)35-23-13-32(14-23)17-34-18-32)26(33)11-22(29)16-38-15-20(3)10-30(38)39/h4-9,11-12,19-20,23,34H,10,13-18H2,1-3H3,(H,35,40)/t20-/m0/s1 |
| InChIKey | WHZNEBSHUSAXCI-FQEVSTJZSA-N |
| XLogP | 5.05 |
| TPSA | 96.45 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 557.67 |
| LogP ≤ 5 | 5.05 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Analyze N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide?
The IUPAC name of N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide (CID 118454747) is N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide.
What is the SMILES notation for N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide?
The canonical SMILES for N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide is CC(C)c1ccc(-c2ccc(Oc3cc(C(=O)NC4CC5(CNC5)C4)c(F)cc3CN3C[C@@H](C)CC3=O)cc2)nn1.
What is the InChIKey of N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide?
The InChIKey is WHZNEBSHUSAXCI-FQEVSTJZSA-N. The full InChI is InChI=1S/C32H36FN5O3/c1-19(2)27-8-9-28(37-36-27)21-4-6-24(7-5-21)41-29-12-25(31(40)35-23-13-32(14-23)17-34-18-32)26(33)11-22(29)16-38-15-20(3)10-30(38)39/h4-9,11-12,19-20,23,34H,10,13-18H2,1-3H3,(H,35,40)/t20-/m0/s1.
What are the key properties of N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide?
N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide has a molecular weight of 557.67 g/mol, XLogP of 5.05, 8 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-azaspiro[3.3]heptan-6-yl)-2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide is sourced from PubChem (CID 118454747), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).